Physician profile
Emily E Masi
NPI 1437881265
$1,090.53
in general payments reported to CMS, 2019-2025
17 companies · $207 in 2025
The $207 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $72.01 · 2023: $346 · 2024: $465 · 2025: $207.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,018.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $183.09 | 2022-2024 | Azstarys |
| Astrazeneca Pharmaceuticals LP | $139.72 | 2023-2024 | Airsupra, Farxiga, Tezspire |
| Genzyme Corporation | $118.98 | 2024 | |
| Abbvie INC. | $105.44 | 2023-2024 | |
| Lilly USA, LLC | $91.88 | 2023-2024 | Jardiance, Mounjaro, Ebglyss |
| Novartis Pharmaceuticals Corporation | $78.50 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $58.04 | 2022-2023 | Dupixent |
| Pfizer INC. | $55.04 | 2023-2025 | |
| Cranial Technologies, INC | $49.83 | 2023-2025 | Doc Band |
| Glaxosmithkline, LLC. | $46.42 | 2024-2025 | Nucala, Arexvy, Shingrix |
| Sage Therapeutics, LLC | $46.37 | 2025 | Zurzuvae |
| Incyte Corporation | $28.62 | 2023 | Opzelura |
| Kaleo, INC. | $21.98 | 2022 | |
| Sanofi Pasteur INC. | $20.32 | 2024 | |
| Novo Nordisk INC | $18.37 | 2024 | Wegovy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $14.19 | 2023 | Seglentis, Livalo |
| Amgen INC. | $13.74 | 2023 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Masi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.